Kontigo Care AB AI Stock Analysis
Want to see SE:KONT full AI Analyst Report?
Kontigo Care AB (KONT) AI Stock Analysis
Kontigo Care AB
(Nasdaq OMX AB:KONT)
The overall score is constrained by weak technicals and a lack of profitability, which heavily impacts valuation. The company's strong revenue growth and pristine, debt-free balance sheet provide a foundation, but until operating leverage improves and the stock price stabilizes, the risk-reward remains unfavorable.
Kontigo Care AB (KONT) vs. iShares MSCI Sweden ETF (EWD)
- Market Cap
- SEK 41.77M
- Dividend Yield
- ―
- Average Volume (3M)
- 23.57K
- Price to Earnings (P/E)
- -42.4
- Beta (1Y)
- -0.03
- Revenue Growth
- 0.97%
- EPS Growth
- 41.35%
- Country
- Sweden
- Employees
- 11
- Sector
- Healthcare
- Sector Strength
- 51
- Industry
- Medical - Healthcare Information Services
Kontigo Care AB Business Overview & Revenue Model
Company Description
Kontigo Care AB (publ) specializes in delivering healthcare solutions aimed at addressing addiction issues within Sweden. Their product portfolio includes Previct Alcohol, a digital medical device designed to manage alcohol dependence, and Previct Ga...
How the Company Makes Money
Kontigo Care AB makes money primarily by selling its remote monitoring solutions to organizational customers (e.g., healthcare providers, clinics, municipalities, or other entities running treatment/rehabilitation programs). Revenue is generally gene...
Kontigo Care AB Financial Statement Overview
Summary
Strong revenue growth (+42.5%) and high gross margins (84.2%) are offset by persistent net losses and negative free cash flow. The debt-free balance sheet is a major strength, but the inability to convert growth into profit is a significant concern.
Income Statement
62PositiveBalance Sheet
78PositiveCash Flow
45Neutral| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 29.56M | 29.13M | 30.24M | 28.95M | 28.43M | 24.54M |
| Gross Profit | 24.89M | 36.56M | 40.08M | 43.73M | 28.24M | 24.16M |
| EBITDA | 5.19M | 3.57M | 5.07M | 1.79M | 4.13M | 90.88K |
| Net Income | -981.00K | -2.07M | 775.00K | 212.00K | 2.90M | -1.20M |
Balance Sheet | ||||||
| Total Assets | 58.49M | 62.12M | 67.74M | 49.77M | 31.39M | 29.20M |
| Cash, Cash Equivalents and Short-Term Investments | 13.24M | 14.95M | 21.86M | 9.85M | 5.74M | 8.48M |
| Total Debt | 0 | 0 | 3.67M | 5.95M | 0 | 1,078 |
| Total Liabilities | 8.79M | 11.62M | 15.42M | 19.05M | 9.98M | 10.74M |
| Stockholders Equity | 49.70M | 50.50M | 52.32M | 30.72M | 21.40M | 18.46M |
Cash Flow | ||||||
| Free Cash Flow | -4.45M | -3.24M | -5.61M | -9.07M | -2.20M | 272.26K |
| Operating Cash Flow | 4.00M | 5.00M | 4.61M | 5.97M | 7.30M | 4.61M |
| Investing Cash Flow | -4.61M | -8.24M | -10.70M | -16.73M | -9.50M | -4.34M |
| Financing Cash Flow | -2.39M | -3.67M | 18.11M | 14.87M | -540.00K | 3.27M |
Kontigo Care AB Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SE:KONT, the sentiment is Negative. The current price of 1.19 is below the 20-day moving average (MA) of 1.32, below the 50-day MA of 1.26, and below the 200-day MA of 1.48, indicating a bearish trend. The MACD of -0.00 indicates Positive momentum. The RSI at 43.15 is Neutral, neither overbought nor oversold. The STOCH value of 32.50 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for SE:KONT.
Kontigo Care AB Peers Comparison
Overall Rating
SE:PTRK59Neutral
SE:SEZI55Neutral
SE:MNTC51Neutral
SE:KONT51Neutral
SE:AINO43Neutral
SE:QLIFE37Underperform
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 59Neutral | SEK 171.55M | -1.95 | ― | ― | -10.30% | -11.59% | |
| 55Neutral | SEK 510.16M | -5.23 | -35.44% | ― | 18.56% | 28.11% | |
| Sector * | 51Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
| 51Neutral | SEK 461.26M | -24.43 | -15.00% | ― | 11.18% | 60.51% | |
| 51Neutral | SEK 41.77M | -42.41 | -1.94% | ― | 0.97% | 41.35% | |
| 43Neutral | SEK 36.00M | -3.44 | 105.04% | ― | -10.72% | -77.78% | |
| 37Underperform | SEK 25.44M | -0.65 | 1852.00% | ― | 142.55% | 73.84% |
* Healthcare Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| SE:KONT | Kontigo Care AB | 1.19 | -0.86 | -42.20% | |
| SE:SEZI | Senzime AB | 3.25 | -1.81 | -35.87% | |
| SE:QLIFE | Qlife Holding AB | 0.88 | -0.47 | -34.69% | |
| SE:AINO | Aino Health AB | 0.18 | -0.03 | -15.38% | |
| SE:MNTC | Mentice AB | 16.40 | 1.30 | 8.61% | |
| SE:PTRK | Physitrack Limited | 10.55 | -4.35 | -29.19% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Oct 20, 2026